BioSpace News Archive

Once fully completed, the Mission Road facility will triple the production capacity in Duncan and increase operational efficiency.

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device and technology company focused on unmet needs in global health, announced today that the FDA has approved its Investigational Device Exemption (IDE) application to initiate an Early Feasibility Study (EFS) of the Company’s proprietary Hemopurifier® in patients with head and neck cancer in combination with standard of care pembrolizumab (Keytruda).

Panelists feature Valensa saw palmetto quality experts and USP’s Edward Wyszumiala, discussing value of USP verification

Doctors suggest that the “adaptive” motion of nickel-titanium rotary files used for root canal procedures decreases the instrument’s torque generation, thereby reducing the risk of tooth damage and file fracture

Recombinetics today announced a collaborative research project with Mayo Clinic to advance Osteogenesis Imperfecta (OI) research by developing the first-ever swine models of OI.